None listed
Conditions
Interventions
None listed
Sponsors
Hallym University Medical Center-Kangnam
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Backward-forward cohort (9000 people) 1) Patients confirmed with COVID-19 between September 1, 2021 and June 30, 2022 and registered as subjects of home treatment at research participating institutions 2) Adults aged 19 or older at the time of signing the consent form 3) A person who is available for all visits according to the planned schedule and is able to comply with the procedures of clinical research; 4) A person who has agreed to comply with the requirements and restrictions listed in the test subject's consent form and the clinical trial plan in writing; ? Forward-looking cohort (1000 people) 1) Patients confirmed with COVID-19 from October 1, 2022. 2) Adults aged 19 or older at the time of signing the consent form 3) A person who is available for all visits according to the planned schedule and is able to comply with the procedures of clinical research; 4) A person who has agreed to comply with the requirements and restrictions listed in the test subject's consent form and the clinical trial plan in writing; ? Control group (1000 people) 1) Subjects who had never been confirmed with COVID-19 at the time of study registration 2) Adults aged 19 or older at the time of signing the consent form 3) A person who is available for all visits according to the planned schedule and is able to comply with the procedures of clinical research; 4) A person who has agreed to comply with the requirements and restrictions listed in the test subject's consent form and the clinical trial plan in writing; ? Inpatient cohort (100 people) 1) Patients who have been confirmed to be COVID-19 and admitted to Hallym University Gangnam Sacred Heart Hospital, or patients who have been registered as participants in the Korea Centers for Disease Control and Prevention's study, "Analyzing the Aftermath and Cell Immunity Patterns of COVID-19 Patients." 2) Adults aged 19 or older at the time of signing the consent form 3) A person who is available for all visits according to the planned schedule and is able to comply with the procedures of clinical research; 4) A person who has agreed to comply with the requirements and restrictions listed in the test subject's consent form and the clinical trial plan in writing;
Exclusion criteria
Exclusion criteria: Not Applicable
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) General Considerations For the continuous data, the mean, standard deviation, median, minimum, and maximum values are obtained, and the average difference between the test group and the placebo group in each Cohort is compared using two sample test. The group-to-group comparison of each Cohort performs ANOVA. In the case of categorical data, frequency and percentage are obtained, and comparison between groups within each Cohort is analyzed using Chi-square test or Fisher's Exact test. Missing values are not replaced in all analyses, and if the causal relationship is missing in the safety analysis, it is judged to be relevant. 2) Demographic information Demographic information is analyzed for all subjects. The continuous data obtain the mean, standard deviation, median, minimum and maximum values and compare the average difference within each Cohort using two sample-test. The comparison of each Cohort is performed by ANOVA. In the case of categorical data, frequency and percentage are obtained, and comparisons within each Cohort are analyzed using Chisquare test or Fisher's Exact test. | — |
Countries
Korea, Republic of
Contacts
Public ContactJacob Lee
Hallym University Medical Center-Kangnam
Outcome results
None listed